Magnus N. Andersson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Magnus N. Andersson has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Annika Björkgren
Department of Radiation Sciences, Oncology and Radiology, Umeå University, Umeå, Sweden
2 shared publicationsErnst Tolocka
Department of Radiation Sciences, Oncology and Radiology, Umeå University, Umeå, Sweden
1 shared publication- Johan Svensson
Department of Statistics, Umeå School of Business, Economics and Statistics, Umeå University, Umeå, Sweden
1 shared publication Malin Sund
Department of Surgical & Perioperative Sciences, Plastic surgery and Surgery, Umeå University, Umeå, Sweden
1 shared publication- Malin Sund
Department of Gastroenterological Surgery University of Helsinki and Helsinki University Hospital Helsinki Finland
1 shared publication Märta A Skoglund
Department of Surgical & Perioperative Sciences, Plastic surgery and Surgery, Umeå University, Umeå, Sweden
1 shared publication
Latest Publications
- Open Access
- 23 January 2022
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 75 (6) , 1813-1819
Prophylactic mastectomy – Correlation between skin flap thickness and residual glandular tissue evaluated postoperatively by imaging
- 23 January 2022
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 75 (6) , 1813-1819
Open AccessProphylactic mastectomy – Correlation between skin flap thickness and residual glandular tissue evaluated postoperatively by imaging
- Open Access
- 1 December 2021
- Published by SAGE Publications in Acta Radiologica
- Vol. 64 (1) , 67-73
Inter- and intra-observer agreement on evaluating the presence of residual glandular tissue with magnetic resonance tomography following prophylactic mastectomy
Background: There are no published international consensus or guideline documents regarding appropriate medical follow-up for women with hereditary increased risk of breast cancer who opt for prophylactic mastectomy. Moreover, it is not known whether breast magnetic resonance imaging (MRI) performed after a prophylactic mastectomy is a reproducible method for evaluating whether clinically relevant amounts of residual glandular tissue remains. Purpose: To evaluate the inter- and intra-observer agreement on detecting residual glandular tissue with MRI. Material and Methods: In total, 40 women previously operated with prophylactic mastectomy underwent MRI and two breast radiologists (R1 and R2) independently assessed the presence of residual glandular tissue. Inter- and intra-rater agreements were assessed using Cohen's kappa (k). Results: Residual glandular tissue was found in 69 of 248 quadrants (27.8%) and 32 of 62 breasts (51.6%) by R1 and 77 of 248 quadrants (31.1%) and 35 of 62 breasts (56.5%) by R2. The interrater agreement was observed to be moderate (k = 0.554) and the intra-rater agreement was observed to be substantial (k = 0.623). Conclusion: In conclusion, the inter-and intra-rater observer agreement in regard to detection of residual glandular tissue was not excellent, which would be desirable for a method considered reproducible enough to be used as a surveillance tool after the surgical procedure in order to ensure that there is no relevant residual glandular tissue remaining warranting further follow-up. More research is needed, as well as establishment of precise protocols, before using the method in risk assessment of remaining glandular tissue and breast cancer risk.
- 1 December 2021
- Published by SAGE Publications in Acta Radiologica
- Vol. 64 (1) , 67-73
Open AccessInter- and intra-observer agreement on evaluating the presence of residual glandular tissue with magnetic resonance tomography following prophylactic mastectomy
Background: There are no published international consensus or guideline documents regarding appropriate medical follow-up for women with hereditary increased risk of breast cancer who opt for prophylactic mastectomy. Moreover, it is not known whether breast magnetic resonance imaging (MRI) performed after a prophylactic mastectomy is a reproducible method for evaluating whether clinically relevant amounts of residual glandular tissue remains. Purpose: To evaluate the inter- and intra-observer agreement on detecting residual glandular tissue with MRI. Material and Methods: In total, 40 women previously operated with prophylactic mastectomy underwent MRI and two breast radiologists (R1 and R2) independently assessed the presence of residual glandular tissue. Inter- and intra-rater agreements were assessed using Cohen's kappa (k). Results: Residual glandular tissue was found in 69 of 248 quadrants (27.8%) and 32 of 62 breasts (51.6%) by R1 and 77 of 248 quadrants (31.1%) and 35 of 62 breasts (56.5%) by R2. The interrater agreement was observed to be moderate (k = 0.554) and the intra-rater agreement was observed to be substantial (k = 0.623). Conclusion: In conclusion, the inter-and intra-rater observer agreement in regard to detection of residual glandular tissue was not excellent, which would be desirable for a method considered reproducible enough to be used as a surveillance tool after the surgical procedure in order to ensure that there is no relevant residual glandular tissue remaining warranting further follow-up. More research is needed, as well as establishment of precise protocols, before using the method in risk assessment of remaining glandular tissue and breast cancer risk.